News Summary

Brainlab, a German medical technology company, has postponed its initial public offering (IPO) in Frankfurt. The decision comes as the European market for new listings continues to face challenges. Originally planned to debut soon, the IPO was expected to be priced lower than the 80-100 euro range initially proposed. This marks another setback for Europe’s IPO market, which has been experiencing difficulties.